Please see below for a list of search results.
This document describes the HTA’s policy on the management and traceability of tissue samples retained by independent pathologists when undertaking post mortem examinations (PME) at HTA-licensed premises where they are not employed.
The aims of this policy are:
Download these standards as a printable PDF.
This position statement outlines guidance provided on consent for post-mortem examination and tissue retention.
The Human Tissue Act 2004 requires that the removal of tissue from the deceased for research within the scope of the Act must always be licensed, on specified premises, and that specific minimum requirements are met.
Flowchart A: Consent and the use of DNA
Flowchart B: Qualifying consent
The definition of relevant material in the Act is:
Section 53: Relevant material:
The HTA conducts stakeholder evaluation every three years, and in 2016/17 it was agreed that it should focus on what the public know, think, and expect about and from the regulator of human tissue.
A series of focus groups were carried out to get in depth feedback on what the public knew...